CORMEDIX INC. - COMMON STOCK
12.42
24-January-25 15:45:00
15 minutes delayed
Stocks
+0.12
+0.98%
Today's range
12.21 - 12.74
ISIN
N/A
Source
NASDAQ
-
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
19 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
15 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
11 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
08 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the Needham Annual Healthcare Conference
27 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
12 Mar 2024 06:30:00 By Nasdaq GlobeNewswire
-
06 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Commercial and Reimbursement Updates
30 Jan 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Commercial and Operational Updates
08 Jan 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Appointment of Chief Legal Officer
15 Dec 2023 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Partnership With The Leapfrog Group
04 Dec 2023 07:30:00 By Nasdaq GlobeNewswire
-
15 Nov 2023 11:57:47 By Nasdaq GlobeNewswire
-
14 Nov 2023 15:05:00 By Nasdaq GlobeNewswire
-
02 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference
11 Oct 2023 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
26 Sep 2023 07:30:00 By Nasdaq GlobeNewswire
-
08 Sep 2023 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference
06 Sep 2023 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath
30 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
08 Aug 2023 06:30:00 By Nasdaq GlobeNewswire